Heidrun Engler

1.1k total citations
18 papers, 887 citations indexed

About

Heidrun Engler is a scholar working on Genetics, Surgery and Molecular Biology. According to data from OpenAlex, Heidrun Engler has authored 18 papers receiving a total of 887 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 7 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Heidrun Engler's work include Virus-based gene therapy research (11 papers), Cancer Research and Treatments (5 papers) and CAR-T cell therapy research (3 papers). Heidrun Engler is often cited by papers focused on Virus-based gene therapy research (11 papers), Cancer Research and Treatments (5 papers) and CAR-T cell therapy research (3 papers). Heidrun Engler collaborates with scholars based in United States, Germany and Japan. Heidrun Engler's co-authors include Todd Machemer, Istvan Szelenyi, Erlinda Quijano, Shu-Fen Wen, Daniel C. Maneval, Thomas Schluep, Robert Connor, Mark E. Davis, Suzie H. Pun and Aijie Liu and has published in prestigious journals such as Journal of Clinical Oncology, Nature Biotechnology and Journal of Medicinal Chemistry.

In The Last Decade

Heidrun Engler

18 papers receiving 842 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heidrun Engler United States 13 468 350 215 173 147 18 887
Huili Lu China 20 481 1.0× 103 0.3× 71 0.3× 316 1.8× 79 0.5× 65 1.0k
Si Myung Byun South Korea 17 349 0.7× 87 0.2× 32 0.1× 75 0.4× 233 1.6× 65 779
Joseph Cherian Singapore 14 520 1.1× 49 0.1× 84 0.4× 64 0.4× 10 0.1× 25 920
Linda P. DiPersio United States 16 249 0.5× 58 0.2× 144 0.7× 109 0.6× 55 0.4× 25 664
Hanie Mahaki Iran 17 413 0.9× 29 0.1× 38 0.2× 221 1.3× 23 0.2× 50 781
Dejun Fan China 13 281 0.6× 47 0.1× 96 0.4× 58 0.3× 45 0.3× 33 605
Y Takakura Japan 16 817 1.7× 240 0.7× 52 0.2× 80 0.5× 17 0.1× 20 1.1k
Sang‐Chul Lee South Korea 17 384 0.8× 51 0.1× 27 0.1× 129 0.7× 36 0.2× 56 833
Steven G. Williams United Kingdom 15 497 1.1× 244 0.7× 50 0.2× 54 0.3× 62 0.4× 30 711
Jingwen Wang China 14 521 1.1× 30 0.1× 40 0.2× 162 0.9× 37 0.3× 70 803

Countries citing papers authored by Heidrun Engler

Since Specialization
Citations

This map shows the geographic impact of Heidrun Engler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidrun Engler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidrun Engler more than expected).

Fields of papers citing papers by Heidrun Engler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heidrun Engler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidrun Engler. The network helps show where Heidrun Engler may publish in the future.

Co-authorship network of co-authors of Heidrun Engler

This figure shows the co-authorship network connecting the top 25 collaborators of Heidrun Engler. A scholar is included among the top collaborators of Heidrun Engler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidrun Engler. Heidrun Engler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Machemer, Todd, Heidrun Engler, Van Tsai, et al.. (2005). Characterization of Hemodynamic Events Following Intravascular Infusion of Recombinant Adenovirus Reveals Possible Solutions for Mitigating Cardiovascular Responses. Molecular Therapy. 12(2). 254–263. 13 indexed citations
2.
Connor, Robert, Jennifer M. Anderson, Todd Machemer, Daniel C. Maneval, & Heidrun Engler. (2005). Sustained intravesical interferon protein exposure is achieved using an adenoviral-mediated gene delivery system: A study in rats evaluating dosing regimens. Urology. 66(1). 224–229. 33 indexed citations
3.
Engler, Heidrun, Todd Machemer, Jennifer Philopena, et al.. (2004). Acute hepatotoxicity of oncolytic adenoviruses in mouse models is associated with expression of wild-type E1a and induction of TNF-α. Virology. 328(1). 52–61. 44 indexed citations
4.
Benedict, William F., Changsoo Kim, Xinqiao Zhang, et al.. (2004). Intravesical Ad-IFNα Causes Marked Regression of Human Bladder Cancer Growing Orthotopically in Nude Mice and Overcomes Resistance to IFN-α Protein. Molecular Therapy. 10(3). 525–532. 76 indexed citations
5.
Pun, Suzie H., Nathalie C. Bellocq, Aijie Liu, et al.. (2004). Cyclodextrin-Modified Polyethylenimine Polymers for Gene Delivery. Bioconjugate Chemistry. 15(4). 831–840. 241 indexed citations
6.
Engler, Heidrun, Todd Machemer, Thomas Schluep, et al.. (2003). Development of a formulation that enhances gene expression and efficacy following intraperitoneal administration in rabbits and mice. Molecular Therapy. 7(4). 558–564. 10 indexed citations
7.
Demers, G W, Duane E. Johnson, Van Tsai, et al.. (2003). Pharmacologic indicators of antitumor efficacy for oncolytic virotherapy.. PubMed. 63(14). 4003–8. 20 indexed citations
8.
Rosser, Charles J., Jain-Hua Zhou, Robert Connor, et al.. (2002). Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancer. Cancer Gene Therapy. 9(8). 687–691. 57 indexed citations
9.
Kuball, Jürgen, Shu Fen Wen, J. Leißner, et al.. (2002). Successful Adenovirus-Mediated Wild-Type p53 Gene Transfer in Patients With Bladder Cancer by Intravesical Vector Instillation. Journal of Clinical Oncology. 20(4). 957–965. 105 indexed citations
10.
Ramachandra, Murali, Amena Rahman, Aihua Zou, et al.. (2001). Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacy. Nature Biotechnology. 19(11). 1035–1041. 113 indexed citations
11.
Engler, Heidrun, Scott C. Anderson, Todd Machemer, et al.. (1999). Ethanol improves adenovirus-mediated gene transfer and expression to the bladder epithelium of rodents. Urology. 53(5). 1049–1053. 41 indexed citations
12.
Engler, Heidrun, Todd Machemer, Scott Anderson, & Daniel C. Maneval. (1999). Enhanced Adenovirus-Mediated Gene Transfer To The Urothelium For Gene Therapy Of Transitional Cell Carcinoma. The Journal of Urology. 120–120. 1 indexed citations
13.
Beck, W, Gerd Geißlinger, Heidrun Engler, & Kay Brune. (1991). Pharmacokinetics of ibuprofen enantiomers in dogs. Chirality. 3(3). 165–169. 26 indexed citations
14.
Engler, Heidrun, et al.. (1990). Cardiohistaminergics - new developments in histamine H_2-agonists. University of Regensburg Publication Server (University of Regensburg). 5 indexed citations
15.
Engler, Heidrun, et al.. (1987). 2-[(3-Pyridinylmethyl)thio]pyrimidine derivatives: New bronchosecretolytic agents. Journal of Medicinal Chemistry. 30(3). 547–551. 9 indexed citations
16.
Buschauer, Armin, et al.. (1986). 1,4-Dihydropyridinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel. University of Regensburg Publication Server (University of Regensburg). 1 indexed citations
17.
Engler, Heidrun & Istvan Szelenyi. (1984). Tracheal phenol red secretion, a new method for screening mucosecretolytic compounds. Journal of Pharmacological Methods. 11(3). 151–157. 48 indexed citations
18.
Szelenyi, Istvan, Stefan Postius, & Heidrun Engler. (1983). Evidence for a functional cytoprotective effect produced by antacids in the rat stomach. European Journal of Pharmacology. 88(4). 403–406. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huili Lu Breakdown of academic impact, for papers by Si Myung Byun Breakdown of academic impact, for papers by Joseph Cherian Breakdown of academic impact, for papers by Linda P. DiPersio Breakdown of academic impact, for papers by Hanie Mahaki Breakdown of academic impact, for papers by Dejun Fan Breakdown of academic impact, for papers by Y Takakura Breakdown of academic impact, for papers by Sang‐Chul Lee Breakdown of academic impact, for papers by Steven G. Williams Breakdown of academic impact, for papers by Jingwen Wang
Rankless by CCL
2026